NATERA INC (Common Stock) – ticker 45E NTRA
$226.55▼ -3.27% 24H
Super Investor & Insider
2
Fondi che lo detengono
#479
Rank consenso
2.9%
% dei portafogli
$234.6M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Lee Ainslie · Maverick Capital | 2.72% | Add 24.11% | 1,171,633 | $234.3M |
| Polen Capital Management · Polen Capital Management | 0% | Reduce 7.78% | 1,269 | $253,787 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Natera Inc. is a diagnostics company specializing in advanced genetic testing services for patients, clinicians, and healthcare systems. The company focuses on analyzing cell-free DNA to support clinical decision-making across several key areas of medicine. Natera’s portfolio includes non-invasive prenatal tests that s…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees4,424
TickerNTRA
Statistics
Market Cap$32.34B
Revenue (TTM)$2.31B
Net Income-$208.2M
Net Margin-9.0%
EPS$-1.62
P/E-144.16
P/S12.40
P/B17.42
EV/EBITDA-112.71
ROE-15.0%
Dividend Yield—
Price$226.55
Data: Twelve Data · Revenue = mcap / P/S